Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Sildenafil may help with some skin conditions and hair growth, but more research is needed.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.